Abstract Diabetic cardiomyopathy is a leading cause of morbidity and mortality, and Insulin2 mutant (Ins2?/-) Akita is a genetic mice model of diabetes relevant to humans. Dicer, miRNAs, and inflammatory cytokines are associated with heart failure. However, the differential expression of miRNAs, dicer, and inflammatory molecules are not clear in diabetic cardiomyopathy of Akita. We measured the levels of miRNAs, dicer, pro-inflammatory tumor necrosis factor alpha (TNFa), and anti-inflammatory interleukin 10 (IL-10) in C57BL/6J (WT) and Akita hearts. The results revealed increased heart to body weight ratio and robust expression of brain natriuretic peptide (BNP: a hypertrophy marker) suggesting cardiac hypertrophy in Akita. The multiplex RT-PCR, qPCR, and immunoblotting showed up regulation of dicer, whereas miRNA array elicited spread down regulation of miRNAs in Akita including dramatic down regulation of let-7a, miR-130, miR-142-3p, miR-148, miR-338, miR-345-3p, miR-384-3p, miR-433, miR-450, miR-451, miR-455, miR-494, miR-499, miR-500, miR-542-3p, miR-744, and miR-872. Conversely, miR-295 is induced in Akita. Cardiac TNFa is upregulated at mRNA (RT-PCR and qPCR), protein (immunoblotting), and cellular (immunohistochemistry and confocal microscopy) levels, and is robust in hypertrophic cardiomyocytes suggesting direct association of TNFa with hypertrophy. Contrary to TNFa, cardiac IL-10 is downregulated in Akita. In conclusion, induction of dicer and TNFa, and attenuation of IL-10 and majority of miRNA are associated with cardiomyopathy in Akita and could be used for putative therapeutic target for heart failure in diabetics.
Introduction
Insulin2 mutant (Ins2?/-) Akita mouse is an attractive animal model for diabetes because Insulin2 gene of mouse is an ortholog of human Insulin, and mutation in Insulin gene causes human juvenile diabetes [1] . Akita mice become diabetic spontaneously at the age of 3-4 weeks and show robust hyperglycemia by 12 weeks [2] [3] [4] [5] [6] [7] . Therefore, it is a better than the induced diabetes models such as NOD-autoimmune depletion of beta cells [8] , OVE 26-the non-specific gene expression of beta cells [9] , and streptozotocin-or alloxan-chemicals destruction of beta cells [10] [11] [12] . These mice develop cardiac fibrosis, endothelium-myocyte uncoupling [5, 13] , impaired contractility of cardiomyocytes and cardiac dysfunction [4, 14] . However, the role of microRNA (miRNA), dicer, and inflammation in diabetic cardiomyopathy in Akita is nebulous.
miRNAs are newly discovered, 19-23 nucleotides long, non-coding regulatory RNAs that modulate gene expression either by mRNA degradation or translational repression [15, 16] . The differential expression of miRNAs is associated with heart failure [17] [18] [19] [20] [21] [22] and diabetes [23] [24] [25] [26] . The distinct role of individual miRNA in cardiac dysfunction is corroborated by the fact that alteration in the levels of miR-133 causes cardiac hypertrophy [27, 28] , arrhythmia [29] [30] [31] , fibrosis [32, 33] , and epigenetic modifications [34] . Therefore, it is important to assess the differential expression of miRNAs in the heart of diabetic Akita. Dicer is an RNase III endonuclease essential for maturation of all pre-miRNAs [26, [35] [36] [37] [38] [39] [40] . Dicer is indispensable for cardiac development because targeted deletion of dicer causes impaired development of ventricular myocardium and pericardial edema that lead to embryonic lethality at day 12.5 [41] . The cardiacspecific knock out of dicer causes progressive dilated cardiomyopathy and ultimately heart failure [42] . Even the conditional deletion of dicer in postnatal myocardium induces cardiomyocytes dysfunction and sudden cardiac arrest [43] . Therefore, dicer plays crucial role in cardiac development and maintenance of cardiac functions. Ablation of dicer also inhibits global miRNA maturation that causes disarray in miRNA mediated regulatory networks. Interestingly, dicer is also regulated by miRNAs such as let-7 in human lung cancer [44] and miR-103/107 in breast cancer [45] . miRNAs also regulates inflammatory molecules including pro-inflammatory cytokine tumor necrosis factor alpha (TNFa) and anti-inflammatory cytokine interleukin-10 (IL-10) [46] [47] [48] [49] . There is a dynamic change in the levels of TNFa and IL-10 during pathological myocardial remodeling [50] . TNFa is not only produced by immune cells but also synthesized by cardiomyocytes in response to injury or stress [51] . The infusion of pathological dose of TNFa promotes left ventricular dysfunction and remodeling in rats [52] . TNFa is also associated with diabetes [53] and contributes to heart failure [54, 55] . On the other hand, IL-10 inhibits TNFa and ameliorates pathological cardiac remodeling [56] [57] [58] . Inflammation exacerbates heart failure [59] , and miRNAs not only regulate inflammation but also play crucial role in pathological cardiac remodeling. However, the differential expression of miRNAs in diabetic Akita is not studied and is important to find out candidate miRNAs involved in diabetic cardiomyopathy in Akita. Therefore, we determined the levels of dicer, miRNAs, TNFa, and IL-10 in Akita hearts.
Materials and Methods

Animal Models
Twelve-week-old male C57BL/6J and Ins2?/-Akita mice were procured from Jackson Laboratory (Bar harbor, ME, USA). Akita mice have same genetic background as C57BL/ 6J mice. Therefore, we used C57BL/6J as wild-type (WT) control for Akita. Mice were kept in the animal facility of University of Louisville with normal chaw diet and drinking water in ad libitum. They were killed following the protocol approved by the Institutional Care and Use Committee of University of Louisville. The standard protocol and guidelines of National Institute of health (NIH) and Guide for the care and use of laboratory animals and the regulation of the Animal Welfare Act was followed.
Experimental Protocols
For measuring the blood glucose level, mice were kept on fasting (without food but with drinking water) for 8 h. To collect blood, tail vein was punctured and 1-2 drops of blood was transferred onto glucose strips of glucometer. The diabetics' mice have the blood glucose level C250 mg/dL and WT mice have B80 mg/dL. Mice (both diabetic and WT) were anesthetized with tribromoethanol (240 mg/kg body weight, i. p.) and hearts were extracted under deep anesthesia. For RNA and protein extraction, hearts were snap frozen in liquid nitrogen and stored at -80°C. For histological sections, hearts were arrested in diastole by injecting 0.2 ml/ 100 g body weight of a 20 % KCl (i. v.) and perfused with 0.9 % saline (Teknova, CA, USA, Catalogue # S5815). They were fixed in 4 % paraformaldehyde and embedded with tissue freezing medium for cryosectioning (5 lM). All experiments were repeated at least three times.
RNA Extraction and Quality Assessment
The miRVana RNA isolation kit Ambion (Part Number #AM1560) was used for RNA isolation. The quality and quantity of RNA was analyzed by NanoDrop 1000, where the ratio of 260:280 and 260:230 with a value of *2 was considered as good quality RNA. The detailed protocol is described elsewhere [60] .
Semi-Quantitative RT-PCR and Quantitative qPCR
We used 1 lg RNA for reverse transcribed by two step protocol of Promega Kit (Promega, WI, USA, # A3800) as elaborated in our previous publication [60] . The PCR program for amplification of dicer, TNFa, IL-10, and 18S was 95°C-7.00 min, (95°C-0.50 min, 55°C-1.00 min, 72°C-1.00 min) 9 34, 72°C-5.00 min and 4°C for infinity. As a loading control, 18S (Ambion # AM1716) was used. The primers used for dicer, TNFa, IL-10, and brain natriuretic peptide (BNP) are as follows: dicer-Forward: 5 For quantitative amplification (qPCR) of mRNA, Stratagene Mx3000P Real-time PCR device was employed. The Syber-green method was used with the PCR cycle of 95°C-10 min; (95°C-0.30 min, 55°C-1.00 min, 72°C-0.30 min) 9 40; 95°C-1.00, and 55°C-0.30 min. The extended protocol is reported in our previous publication [60] .
Multiplex RT-PCR
To rule out the variation in RNA quantity and quality, and initial quantization errors during PCR, we used multiplex RT-PCR to amplify dicer in WT and Akita hearts. Multiplex RT-PCR amplifies two sets of primer in a single PCR, where one primer set acts as invariant endogenous control (18S), while the other amplifies the target gene (dicer, IL-10, TNFa and BNP). Gel electrophoresis show two bands; one for endogenous control and other for the target gene.
miRNA Assay
The miRNA array and individual assay was performed using Applied Biosystems kit and following their protocols. The Taqman microRNA reverse transcription kit (Part #4366596), miR-223 (Part #007896), and sno234 (endogenous control) (Part #1234) were used and the protocol is elaborated elsewhere [60] .
Protein Extraction and Western Blotting
Proteins were extracted from snap frozen hearts using radio-immuno-precipitation assay (RIPA, catalogue # BP-115D, Boston BioProducts, MA, USA) lyses buffer. The quantity of proteins was estimated by Bradford method using SoftMax Pro 4.6 program and Molecular Devices plate reader. The routine Western blotting was performed using SDS-PAGE gel electrophoresis. The primary antibodies of TNFa (LS Biosciences, WA, USA; # C18838), IL-10 (LS Biosciences, WA, USA; # B4913), Dicer (Santa Cruz Biotech; # sc-30226) and GAPDH (Millipore, CA, USA; # MAB 374) were diluted in the ratio of 1:1,000. The secondary antibodies, anti-mouse IgG-HRP (Santa Cruz Biotech; # sc-2005), and anti-rabbit IgG-HRP (Santa Cruz Biotech; # sc-2054) were diluted in the ratio of 1:3,000. We also used secondary antibody for molecular size marker (BioRad Precision Protein Strep Tactin-HRP conjugate, (Bio-Rad, CA, USA; #161-0381). The membranes were developed and band intensity was analyzed by ChemiDoc software (BioRad, CA, USA).
Multiplex-Immunoblotting
To analyze the expression of target (TNFa) and control (GAPDH) proteins simultaneously, we incubated the nitrocellulose membranes with the primary antibodies of both TNFa and GAPDH. Similarly, the secondary antibodies corresponding to both TNFa and GAPDH were used. The membranes were developed as routine Western blotting and band intensity was analyzed for quantification.
Immunohistochemistry (IHC) and Confocal Microscopy
The IHC and confocal microscopy protocols were same as described earlier [13, 61] . In brief, histological sections of the heart from WT and Akita mice were washed with phosphate buffered saline (PBS) (Invitrogen, GIBCO, #14190), permeabilized with 0.02 % Triton X-100 (Fisher BioReagents, #BP-151) for 20 min, washed with PBS (three time for 5 min), blocked with 1 % BSA in PBS, incubated with TNFa (LS Biosciences, WA, USA; # C18838), and BNP (Bioss # bs-2207R Cy5) primary antibodies, separately (1:100 dilution) for overnight at 4°C, washed with PBS, incubated with anti-rabbit Alexa-fluor 647 (Invitrogen; #A21245) diluted in the ratio of 1:200 for 2 h at room temperature, washed with PBS, incubated with DAPI (1:1,000 dilution) for 30 min, mounted with FluoroGel (GTX; #28214) and observed under confocal microscope (Olympus). The intensity of red color was determined by Image-Pro software to compare the cellular expression of TNFa and BNP in WT and Akita hearts.
Statistical Analyses
All the statistical values were presented as mean ± SE. Student t test was performed to calculate the differences in mean between two groups. A p value of \0.05 was considered as statistically significant difference.
Results
Cardiac Hypertrophy in Akita
The geometrical shape of heart in WT is elongated (American football) but in Akita, it is changed to round shape (soccer ball) (Fig. 1Ai) , which is common in dilated cardiomyopathy [62] . To determine cardiac hypertrophy, we measured the heart to body weight ratio (HW/BW) in WT and Akita hearts (Fig. 1Aii) . The significant increase in HW/BW in Akita (Fig. 1Aii) suggests cardiac hypertrophy. To corroborate the finding at molecular level, we measured the levels of hypertrophy markers BNP and betamyosin heavy chain (b-MHC) by qPCR (Fig. 1Bi, C) and IHC (Fig. 1Bii a, b) in the heart tissue of both WT and Akita. There is robust upregulation of BNP in Akita hearts (Fig. 1Bi , ii, C) extending support to cardiac hypertrophy.
Dicer is Induced in Akita Hearts
Dicer level is low in end-stage heart failure but elevated in the hearts with left ventricle assist device (LVAD) [42] . Therefore, we measured dicer at mRNA and protein levels in WT and Akita hearts. The multiplex RT-PCR (Fig. 2Ai , ii) and qPCR (Fig. 2B) show increased transcription of dicer in Akita, which is translated into protein (Fig. 2Ci, ii) . The increased level of dicer is similar to the condition of LVAD, where the heart is in remodeling stage [42] .
miRNAs are Attenuated in Akita Hearts
Since differential expression of miRNAs contributes to pathological cardiac remodeling leading to heart failure [18, 26] , we measured the levels of miRNAs in WT and Akita hearts using miRNA array. The miRNA array analyses revealed that out of 242 miRNAs, 65 miRNAs are attenuated, where let-7a, miR-345-3p, miR-384-3p, miR-433, and miR-455 are *80 % down regulated in Akita (Fig. 3A, B) . Conversely, miR-295 is induced (*threefold up regulated) in Akita (Fig. 3B) . We also confirmed the results by individual miRNA assay, which is in line with the miRNA array analyses (Fig. 3C, D) . Since miR-223 is anti-inflammatory and cardio-protective [63, 64] , we also measured the levels of miR-223. The results show significant down regulation of miR-223 in Akita hearts (Fig. 3E) .
TNFa is Induced and Associated with Cardiac Hypertrophy in Akita
Since TNFa is a pro-inflammatory cytokine that contributes to heart failure [54, 55] , we measured the levels of TNFa in WT and Akita hearts. The RT-PCR (Fig. 4Ai, ii) , and qPCR (Fig. 4B ) results show significant up-regulation of TNFa mRNA in Akita suggesting its increased transcription. We used two endogenous controls (18S and GAPDH) to verify the induction of TNFa in Akita hearts (Fig. 4A, B) . The multiplex-immunoblotting show that transcriptional message is translated at protein level in Akita hearts (Fig. 4Ci, ii) . We also determined the cellular levels of TNFa in WT and Akita hearts using IHC and confocal microscopy. There is increased expression of TNFa in Akita hearts (Fig. 4Di, ii) . In the ventricular sections of Akita hearts, TNFa is mostly localized in the hypertrophic (comparatively bigger in size than the normal cardiomyocytes) cardiomyocytes (indicated by arrow), and almost absent in the normal size cardiomyocytes (indicated by star) (Fig. 4E) . The localization of TNFa with hypertrophic cardiomyocytes suggests that TNFa is directly associated with cardiac hypertrophy in diabetic Akita.
IL-10 is Attenuated in Akita Hearts
The anti-inflammatory IL-10 is measured in WT and Akita hearts at both mRNA and protein levels. The RT-PCR (Fig. 5Ai , ii) and qPCR (Fig. 5B) analyses show inhibition of transcription of IL-10 in Akita hearts. The immunoblotting results revealed that mRNA message is translated at protein levels in Akita (Fig. 5C ). The mitigation of IL-10 suggests inhibition of anti-inflammatory cytokine in Akita hearts.
Discussion
Despite development in therapy regime, heart failure is a leading cause of morbidity and mortality in the world [65] . The incidence of heart failure increases 2-4 folds with diabetes [66] , which is rapidly increasing across the globe [67, 68] . However, the mechanism of heart failure in diabetes is still elusive. The newly discovered non-coding, tiny miRNAs are emerged as novel class of regulatory RNA that plays pivotal role in diabetes and heart failure [17, 18, 20, 25, 26, 69] . It is documented that differential expression of specific miRNA contributes to heart failure such as miR-1, -133, -150 in hypertrophy, miR-29, -133 in fibrosis, miR-1, -133 in arrhythmia, and miR-126 in angiogenesis [26, 31] . The miRNA maturation enzyme dicer is also reported to alter in the pathological condition and reverse cardiac remodeling [42] . It is documented that miRNA regulates inflammation [48, 64, 70, 71] , which is induced in stress condition and contributes to heart failure [53, 59, 72, 73] . The pro-inflammatory TNFa plays key role in myocardial remodeling [54] [55] [56] and blocking of TNFa reverses the LV remodeling [55] . On contrary, induction of anti-inflammatory IL-10 suppresses TNFa [56] , and attenuates LV remodeling after myocardial infarction (MI) [57] . The genetic deletion of IL-10 exacerbates but IL-10 treatment ameliorates pressure overload-induced pathological cardiac remodeling [58] suggesting that IL-10 is a potent anti-inflammatory cytokine. Therefore, we investigated the cardiac levels of dicer, miRNAs, TNFa, and IL-10 in diabetic Akita. It is reported that the geometry of left ventricle (LV) alters to spherical dilatation in the apex in the failing heart [74] . We found that shape of Akita heart has tendency to become spherical in the apical region of LV when compared to the WT heart (Fig. 1Ai) . It extends support to cardiomyopathy of Akita hearts [14, 75] . The pathological condition of the heart is also evaluated by cardiac hypertrophy, where cardiomyocytes increase in size making the heart bigger than the normal size. The cardiac hypertrophy often is assessed by HW/BW ratio and at molecular level by BNP expression. In Akita, increase in HW/BW (Fig. 1Aii ) and significant upregulation of BNP (Fig. 1Bi , ii) and b-MHC (Fig. 1C) suggest cardiac hypertrophy. It supports pathological cardiac remodeling and dysfunction in diabetes [4, 5, 75] . These changes are accompanied by induction of dicer both at mRNA and protein levels (Fig. 2Ai, Cii) . However, miRNAs are largely attenuated ( Fig. 3A-E ) except miR-295 (Fig. 3B) . Since targeted deletion of dicer attenuates mature miRNAs [42] , upregulation of dicer is anomalous to downregulation of miRNAs in Akita hearts. In the failing heart dicer is significantly down regulated but LVAD improves dicer to a moderate level [42] . The induction of dicer in Akita can be explained by simulating the condition of the heart maneuvering to reverse the pathological remodeling as in case of LVAD. The spread downregulation of miRNAs in Akita hearts suggests inhibition of biogenesis of majority of miRNAs in diabetes. The miRNA profiling revealed several candidate miRNAs such as let-7a, miR-130a, -142-3p, -148,-338, -345-3p, -384-3p, -433, -450, -451, -455, -499, -500, -542-3p, -744, and -872, which are down regulated, and miR-295, which is upregulated in diabetic Akita (Fig. 3A, B) . It is reported that miR130a is involved in angiogenesis [76] . In Akita, miR-130a is *70 % downregulated that may have implications on angiogenesis. Similarly, inhibition of miR-133a is associated with cardiac hypertrophy [27] , fibrosis [33] , and matrix remodeling [77] . The cardiac hypertrophy (Fig. 1Aii, B) and fibrosis [5] in Akita is in line with the above findings. The only miRNA we found upregulated in Akita is miR-295 (Fig. 3A) . It is documented that miR-295 is a mammalianspecific miRNA that express especially in early embryonic stage [78] . In the failing heart, miRNAs undergo fetal reprogramming that is switching of expression profile from adult to embryonic condition [79] . Fetal reprogramming is an adaptive mechanism to recover from adverse condition. The *three-fold increase in the levels of miR-295 suggests pathological condition of Akita hearts. The miR-223 is an anti-inflammatory miRNA [80] . The attenuation of miR-223 in Akita hearts suggest increased inflammation. Although inflammation can be cardioprotective in damaged myocardium if triggered ephemerally [81] , chronic inflammation is detrimental [82] . The robust upregulation of pro-inflammatory TNFa in Akita at mRNA (Fig. 4Ai, B) , protein (Fig. 4Ci , ii), and cellular (Fig. 4Di , ii) levels corroborates induction of inflammation in Akita hearts. Since TNFa causes LV remodeling [54, 55] , and beta-adrenergic receptor-mediated cardiac hypertrophy [83] , we localized TNFa at cellular level both in normal and hypertrophic cardiomyocytes. The increased level of TNFa in the hypertrophic cardiomyocytes (shown by arrow head in Fig. 4E ), and decreased level of TNFa in normal cardiomyocytes (pointed with asterisk in Fig. 4E ) suggests a direct association of TNFa with cardiac hypertrophy in Akita. The increased inflammation is also attributed to the inhibition of IL-10. It is documented that IL-10 suppresses TNFa-induced cardiomyocytes apoptosis [56] . Also, IL-10 inhibits inflammation and mitigates pathological LV remodeling [57] . We found that IL-10 is downregulated in Akita both at mRNA (Fig. 5Ai, B) and protein (Fig. 5Ci , ii) levels indicating the inflammation-mediated cardiac dysfunction in Akita.
Conclusion
Diabetic cardiomyopathy in Akita is associated with differential expression of dicer, miRNAs, TNFa, and IL-10. The localization of TNFa in hypertrophic cardiomyocytes points to role of TNF in cardiac hypertrophy. Our results revealed several novel putative candidate miRNAs involved in diabetic cardiomyopathy. 
